EU Safety Gate (RAPEX) · Sweden · 2022-03-11 · Serious risk
🌐Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Reported risk: Enligt ingrediensförteckningen innehåller produkten en blandning av konserveringsmedlen metylklorisotiazolinon och metylisotiazolinon (MCI och MI), som är förbjudna i leave-on-kosmetika. Hudkontakt med produkter som innehåller MCI och MI kan framkalla allergiskt kontakteksem hos känsliga personer. Produkten uppfyller inte kraven i kosmetikaförordningen.
Action taken by the authority
Type of economic operator to whom the measure were ordered
Retailer
Category of measure
Ban on the marketing of the product and any accompanying measures
Date of entry into force
17/11/2021
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.
Product Name (original English): Sequence Lightening Beauty Lotion
Risk Description (original English): According to the list of ingredients the product contains a mixture of the preservatives methylchloroisothiazolinone and methylisothiazolinone (MCI and MI), which are forbidden in leave-on cosmetics. Dermal contact with MCI and MI containing products can provoke allergic contact dermatitis in sensitive persons.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.